Real-World Evidence — What Is It and What Can It Tell Us?
2016 · New England Journal of Medicine · 1,989 citations
https://doi.org/10.1056/nejmsb1609216
G
Gerald J. Dal Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
6.9K
Citations
36
h-index
84
i10-index
Gerald J. Dal Pan is an academic researcher from United States Food and Drug Administration. The author has contributed to research in topics: Pharmacovigilance and Adverse Drug Reactions & Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Economics and Policy. The author has an h-index of 36, co-authored 133 publications.
ORCID: 0000-0003-4874-5864Papers by this author
worksProcess guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center
2024 · BMJ · 51 citations
https://doi.org/10.1136/bmj-2023-076460
Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals
2017 · Drug Safety · 50 citations
https://doi.org/10.1007/s40264-017-0526-1
Patient-Reported Opioid Analgesic Use After Discharge from Surgical Procedures: A Systematic Review
2021 · Pain Medicine · 9 citations
https://doi.org/10.1093/pm/pnab244
Self-healing keratin-based cryogel: A pharmaceutical-free, biomaterial for wound healing, antibacterial protection, and regenerative therapeutics
2025 · Materials & Design · 3 citations
https://doi.org/10.1016/j.matdes.2025.114314
Physician Experiences With and Perspectives on Clozapine Prescribing
2025 · JAMA Network Open · 2 citations
https://doi.org/10.1001/jamanetworkopen.2024.59311
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat